- Home
- SPGI vs ABT Comparison
SPGI vs ABT Comparison
Compare SPGI & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPGI | ABT |
|---|---|---|
| Founded | 1860 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5B | 189.6B |
| IPO Year | 1994 | 2006 |
Fundamental Metrics
Financial Performance| Metric | SPGI | ABT |
|---|---|---|
| Price | $427.32 | $108.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 15 | 16 |
| Target Price | ★ $567.73 | $139.38 |
| AVG Volume (30 Days) | 2.2M | ★ 6.6M |
| Earning Date | 05-12-2026 | 04-23-2026 |
| Dividend Yield | 0.90% | ★ 2.28% |
| EPS Growth | ★ 18.70 | N/A |
| EPS | ★ 14.66 | 3.72 |
| Revenue | $6,063,000,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $9.70 | $8.92 |
| Revenue Next Year | $7.36 | $7.39 |
| P/E Ratio | ★ $29.61 | $29.87 |
| Revenue Growth | ★ 7.10 | 5.67 |
| 52 Week Low | $381.61 | $105.27 |
| 52 Week High | $579.05 | $137.49 |
Technical Indicators
Market Signals| Indicator | SPGI | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 42.23 | 39.51 |
| Support Level | $415.92 | $105.27 |
| Resistance Level | $451.66 | $113.76 |
| Average True Range (ATR) | 9.11 | 1.97 |
| MACD | 1.76 | -0.24 |
| Stochastic Oscillator | 32.15 | 5.98 |
Price Performance
Historical ComparisonAbout SPGI S&P Global Inc.
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.